Fullerton-based Beckman Instruments Inc. manufactures, markets and services laboratory instrument systems, reagents and related products which are used to conduct basic scientific research, new product research and development or diagnostic analysis of patient samples. The company’s products are used for diagnostic and life science applications by medical schools, hospital laboratories and others. For the third quarter ended Sept. 30, net sales totaled $271.6 million vs. $252.8 million a year ago. Net income increased to $19.4 million, or sixty-eight cents per share vs. $18.7 million, or sixty-five cents per share a year ago. The earnings for the third quarter were diluted five cents per share associated with the aquisition of the Access immunoassay product line that came in the second quarter.
FINANCIAL DATA
Year ending Dec. 31 1996 1995 1994 Total revenue, in millions $1,028.0 $930.1 $888.6
Net income (loss), in millions $74.7 $48.9 $42.2
Earnings per share $2.58 $1.70 $1.50
Share Data Balance Sheet
Shares outstanding 28.41 million Longterm debt $176 million
Market capitalization $1181.0 million Book value/share $14.00
Institutional ownership 72.53% Dividend per share/year $.60
Analyst coverage 9 EPS trailing 12 mos. $2.75
52 week range 35 – 52 5/16 P/E estimate FY97 30.63
Latest quarterly earnings report $.68 vs. $.65 (Sept 30, 1997 vs. Sept 30,1996)
Company Information
Louis T. Rosso chairman/CEO 2500 Harbor Blvd. John P. Wareham president/COO Fullerton 92834
871-4848
compiled by Drew S. Roth, Meridian Capital Group Inc.
